Karyopharm Therapeutics Inc. - 8-K Filing
Karyopharm Therapeutics Inc. implemented a retention program for key executives including its CEO with cash awards ranging from $625k to $1.725m. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)
Tickers: $KPTI